Brackmann Christoph
Chief Financial Officer
Brackmann Christoph has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Mar 5, 2026.
On the most recent filing, Brackmann Christoph is listed as Chief Financial Officer at NovoCure Ltd. Inside the rolling window, Brackmann Christoph reported no open-market purchases and 1 open-market sale totaling $85K in NVCR.
Companies traded
Other insiders at NVCR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$85K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Brackmann Christoph made?
Brackmann Christoph has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Brackmann Christoph trade?
Brackmann Christoph has filed SEC Form 4 disclosures for 1 company, including NVCR.
When was Brackmann Christoph's most recent SEC Form 4 filing?
Brackmann Christoph's most recent SEC Form 4 filing on Tracefour is dated Mar 5, 2026.
What is Brackmann Christoph's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Brackmann Christoph is listed as Chief Financial Officer.
What is Brackmann Christoph's total buy and sell value in the current window?
Inside the rolling retention window, Brackmann Christoph bought $0 and sold $85K based on SEC Form 4 filings.
What was Brackmann Christoph's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,412 NVCR shares on 2026-03-04, worth $85K, per SEC Form 4 filings.